相关实验视频
Updated: Jan 9, 2026
08:16
Movement Retraining using Real-time Feedback of Performance
Published on: January 17, 2013
13.7K
对运动障碍治疗方法的审查
1Department of Electrical Engineering. Na.C., Islamic Azad University, Najafabad, Iran; Digital Processing and Machine Vision Research Center, Na.C., Islamic Azad University, Najafabad, Iran.
Behavioural brain research
|December 6, 2025
概括
运动障碍会因为神经肌肉或肌肉骨问题而损害日常功能. 本综述涵盖了诸如康复和手术等原因和治疗方法,以改善运动功能和减少残疾.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 整形外科 整形外科 整形外科
背景情况:
- 运动对于人类的功能和生活质量至关重要.
- 影响神经肌肉和肌肉骨系统的病理会导致运动功能障碍.
- 准确的诊断和基于证据的疗法对于管理运动障碍至关重要.
研究的目的:
- 为了研究运动障碍的多因素病原性.
- 为运动障碍提供当前治疗方法的全面审查.
主要方法:
- 关于运动障碍的科学文章的文献综述.
- 分析病原和当前的治疗策略.
- 综合有关康复,药理学,手术和新兴疗法的信息.
主要成果:
- 运动障碍源于影响运动控制的复杂,多因素的原因.
- 目前的治疗策略包括康复,药理干预,手术选择和新型治疗方法.
- 针对患者的具体干预是优化结果的关键.
结论:
- 了解运动障碍的发病因子对于有效管理至关重要.
- 经常需要一种多学科的方法,结合各种治疗方式.
- 个性化治疗选择最大限度地恢复运动功能的潜力,并最大限度地减少患者的残疾.
相关概念视频
01:24Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:28Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
01:24Treatment Strategies for Psychological Disorders
666
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
666
01:22Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764